Fonar's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics

What is ROE for Fonar in the third quarter 2026?
Fonar Corporation achieved a return on average equity (ROE) of 5.26 % in its third quarter 2026, which is below Fonar's average return on equity, which stands at 81.99%.

ROE decreased relative to the period ending , due to the decline in net income.

Within the Medical Equipment & Supplies industry 53 other companies had a higher return on equity. While return on equity, the total ranking has deteriorated compared to the second quarter 2026 from 1489 to 1922.

What is ROE?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Equity ROE▼

None ▼

Return on Equity ROE▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Equity	(Mar 31 2026) III. Quarter	(Dec 31 2025) II. Quarter	(Sep 30 2025) I. Quarter	(Jun 30 2025) IV. Quarter	(Mar 31 2025) III. Quarter
Y / Y Equity Change	2.62 %	2.46 %	1.62 %	2.12 %	-
Y / Y Net Income Change	-24.99 %	22.01 %	-33.25 %	-32.97 %	19.41 %
Net Income (TTM) in Millions	9	9	9	10	11
Return On Equity (TTM)	5.26 %	5.75 %	5.5 %	6.36 %	6.73 %
FONR's Total Ranking	# 1922	# 1489	# 1418	# 1561	# 1532
Equity (TTM) in Millions	164	163	161	160	160
Seq. Equity Change	0.98 %	0.91 %	0.81 %	-0.1 %	0.82 %
Seq. Net Income Change	-12.41 %	-4.91 %	143.72 %	-63.05 %	42.48 %

Back to FONR Management Effectiveness >> FONR's 5 Years Annual ROE >> Compare FONR ROE to its Competitors

Return On Equity Company Ranking
Within:	No.
Industry	# 54
Sector	# 168
Overall	# 1922

Return On Equity Statistics
High	Average	Low
459.79 %	81.99 %	5.26 %
(Mar 31 2018)		(Mar 31 2026)

FONR Annual Return On Equity	(Jun 30 2025) 2025	(Jun 30 2024) 2024	(Jun 30 2023) 2023	(Jun 30 2022) 2022	(Jun 30 2021) 2021
Total Equity in Millions	160	157	151	146	135
Y / Y Equity Change	2.12 %	3.95 %	3.14 %	8.03 %	7.23 %
Net Income in Millions	10	14	12	17	14
Y / Y Net Income Change	-28.06 %	16.25 %	-29.64 %	26.04 %	16.82 %
Return On Equity	6.33 %	8.99 %	8.04 %	11.79 %	10.1 %

Back to FONR Management Effectiveness >> FONR's 5 Years Annual ROE >> Compare FONR ROE to its Competitors

Annual Roe Comment

In 2025 ROE decreased compared to the previous year to 6.33 %, due to deterioration of net income.

More Return On Equity Ratios
Medical Equipment & Supplies Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
FONR's' Return on Equity at Yahoo Finance
FONR's Roe Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for FONR's Competitors
Subscribers only: Roe for Fonar's Suppliers
Subscribers only: Return On Equity for FONR's Customers

Companies with similar Return On Equity at Mar 31 2026, within Healthcare Sector	ROE
Regeneron Pharmaceuticals Inc	14.32 %
Infusystem Holdings Inc	14.00 %
Ardent Health Inc	13.71 %
Healthcare Services Group Inc	13.60 %
Alpha Pro Tech Ltd	13.43 %
Royalty Pharma Plc	13.42 %
Progyny Inc	13.34 %
Kiniksa Pharmaceuticals International Plc	13.26 %
Globus Medical Inc	13.04 %
Mimedx Group Inc	12.86 %
Nature s Sunshine Products inc	12.56 %
Penumbra Inc	12.32 %
Abbott Laboratories	12.09 %
Beone Medicines Ltd	12.06 %
National Healthcare Corp	11.89 %
Haemonetics Corporation	11.62 %
Steris Plc	11.29 %
Dr Reddy s Laboratories Limited	11.15 %
Cadre Holdings inc	11.11 %
Labcorp Holdings Inc	10.92 %
Viemed Healthcare Inc	10.86 %
U S Physical Therapy Inc	10.79 %
Align Technology inc	10.70 %
Siga Technologies Inc	10.60 %
Edwards Lifesciences Corporation	10.55 %
Henry Schein Inc	10.50 %
Entrada Therapeutics Inc	10.40 %
Amphastar Pharmaceuticals Inc	10.23 %
Select Medical Holdings Corp	10.05 %
Pacific Health Care Organization Inc	9.95 %

Date modified: 2026-09-26T06:53:12+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.